2022 - An Accelerated Approach to Strategic Regulatory Compliance
Date2022-12-05
Deadline2022-12-05
VenueWebinar, USA - United States
KeywordsSupply Chain; Regulatory; Global Clinical Trials
Topics/Call fo Papers
Regulatory compliance is a critical aspect of the pharmaceutical and life sciences landscape. Maintaining GMP/GDP and other industry standards requires dedicated knowledge and regulatory expertise to manage timelines and quality control. As the supply chain becomes more complex, the greater the challenges to managing compliance and developing systems for data collection. When it comes to meeting regulatory standards, being prepared is integral to success and failure is a loss of resources.
Current events play a key role in developing a strategic policy, and sanctions, embargoes and international emergencies affect the response to regulatory compliance. Mitigating risks, avoiding violations and streamlining mandatory processes are paramount to creating an operational protocol for building reliable global pathways.
Join the featured speaker, a Certified Customs Specialist and regulatory expert, in this informative webinar to learn how being prepared for regulatory challenges can improve the time it takes to bring a product to market, increase market share and reduce risk of infractions that jeopardize success.
Current events play a key role in developing a strategic policy, and sanctions, embargoes and international emergencies affect the response to regulatory compliance. Mitigating risks, avoiding violations and streamlining mandatory processes are paramount to creating an operational protocol for building reliable global pathways.
Join the featured speaker, a Certified Customs Specialist and regulatory expert, in this informative webinar to learn how being prepared for regulatory challenges can improve the time it takes to bring a product to market, increase market share and reduce risk of infractions that jeopardize success.
Other CFPs
- Liquid Biopsy Assays: Beyond Recurrence Detection in Post-Diagnosis Cancer Management
- Utilizing State-of-the-Art DEL Technology to Discover Compounds that Hit Challenging Therapeutic Targets
- AAV Manufacturing — Overcoming the Challenges of Plasmid DNA
- Risk Assessment: Traditional and Novel Approaches to Assess and Manage Risks
- Constructing a Pharma Development & Manufacturing Project Plan: Steps to Evaluate Risk & Find Efficiencies
Last modified: 2022-11-02 02:12:26